This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Summary
Eosin is a medication used to disinfect small skin wounds, bug bites, and sores.
- Generic Name
- Eosin
- DrugBank Accession Number
- DB13706
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Eosin (DB13706)
- Weight
- Average: 691.859
Monoisotopic: 687.674414 - Chemical Formula
- C20H6Br4Na2O5
- Synonyms
- Acid red 87
- Eosine Yellowish
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Therapies
- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
Categories
- ATC Codes
- D08AX02 — Eosin
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as xanthenes. These are polycyclic aromatic compounds containing a xanthene moiety, which consists of two benzene rings joined to each other by a pyran ring.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Benzopyrans
- Sub Class
- 1-benzopyrans
- Direct Parent
- Xanthenes
- Alternative Parents
- Benzoic acids / Benzoyl derivatives / Phenoxides / Aryl bromides / Heteroaromatic compounds / Carboxylic acid salts / Cyclic ketones / Oxacyclic compounds / Carboxylic acids / Organic metal halides show 6 more
- Substituents
- Aromatic heteropolycyclic compound / Aryl bromide / Aryl halide / Benzenoid / Benzoic acid / Benzoic acid or derivatives / Benzoyl / Carboxylic acid / Carboxylic acid derivative / Carboxylic acid salt show 18 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- organobromine compound, organic sodium salt (CHEBI:52053)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- TDQ283MPCW
- CAS number
- 17372-87-1
- InChI Key
- SEACYXSIPDVVMV-UHFFFAOYSA-L
- InChI
- InChI=1S/C20H8Br4O5.2Na/c21-11-5-9-13(7-3-1-2-4-8(7)20(27)28)10-6-12(22)17(26)15(24)19(10)29-18(9)14(23)16(11)25;;/h1-6,25H,(H,27,28);;/q;2*+1/p-2
- IUPAC Name
- disodium 2-(2,4,5,7-tetrabromo-6-oxido-3-oxo-3H-xanthen-9-yl)benzoate
- SMILES
- [Na+].[Na+].[O-]C(=O)C1=C(C=CC=C1)C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C1C=C(Br)C([O-])=C2Br
References
- General References
- Not Available
- External Links
- ChemSpider
- 10580
- 1310593
- ChEBI
- 52053
- ChEMBL
- CHEMBL411675
- Wikipedia
- Eosin
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Topical Solution Topical 1 % Solution Topical 2 % Solution Cutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.00126 mg/mL ALOGPS logP 6.12 ALOGPS logP 5.99 Chemaxon logS -5.7 ALOGPS pKa (Strongest Acidic) 3.39 Chemaxon pKa (Strongest Basic) 1.98 Chemaxon Physiological Charge -2 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 89.49 Å2 Chemaxon Rotatable Bond Count 1 Chemaxon Refractivity 155.26 m3·mol-1 Chemaxon Polarizability 46.14 Å3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-0006-1300019000-81dd512a1bd4313ec32e - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 192.0877194 predictedDarkChem Lite v0.1.0 [M-H]- 186.14651 predictedDeepCCS 1.0 (2019) [M+H]+ 191.3459194 predictedDarkChem Lite v0.1.0 [M+H]+ 188.50452 predictedDeepCCS 1.0 (2019) [M+Na]+ 191.0987194 predictedDarkChem Lite v0.1.0 [M+Na]+ 194.77847 predictedDeepCCS 1.0 (2019)
Drug created at June 23, 2017 20:47 / Updated at May 29, 2021 18:12